Volume 137, Issue 5, Pages (November 2009)

Slides:



Advertisements
Similar presentations
TRS1 rpS6 28S 18S B A Oligo(dT) Input +MN TRS1 +m 7 GTP His PABP Figure S1. pTRS1 associates with the mRNA body independent of the.
Advertisements

Volume 131, Issue 1, Pages (July 2006)
Volume 56, Issue 5, Pages (November 1999)
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Figure 1. Enhancement of ERα activity by Constitutively Active MEKK1 in Endometrial Cancer Cells A, Ishikawa cells were transfected with 0.5 μg EREe1bCAT.
Volume 138, Issue 3, Pages (March 2010)
Volume 130, Issue 3, Pages (March 2006)
Volume 145, Issue 2, Pages (August 2013)
Volume 129, Issue 3, Pages (September 2005)
Volume 132, Issue 5, Pages (May 2007)
Volume 133, Issue 2, Pages (August 2007)
Volume 131, Issue 1, Pages (July 2006)
Replication of Hepatitis C Virus Genotype 3a in Cultured Cells
HIV Increases HCV Replication in a TGF-β1–Dependent Manner
Volume 126, Issue 1, Pages (January 2004)
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 145, Issue 6, Pages e1 (December 2013)
Volume 132, Issue 4, Pages (April 2007)
Volume 128, Issue 1, Pages (January 2005)
Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes  Ying Shan, Jianyu Zheng, Richard.
Volume 141, Issue 3, Pages (September 2011)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 128, Issue 4, Pages (April 2005)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 140, Issue 3, Pages e3 (March 2011)
Volume 129, Issue 5, Pages (November 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 20, Issue 4, Pages (April 2013)
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 135, Issue 1, Pages (July 2008)
Volume 142, Issue 3, Pages (March 2012)
Zinc Mesoporphyrin Induces Rapid Proteasomal Degradation of Hepatitis C Nonstructural 5A Protein in Human Hepatoma Cells  Weihong Hou, Qing Tian, Jianyu.
Volume 144, Issue 1, Pages e6 (January 2013)
Volume 126, Issue 1, Pages (January 2004)
Volume 87, Issue 7, Pages (December 1996)
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 56, Issue 5, Pages (November 1999)
Volume 133, Issue 5, Pages (November 2007)
A Mechanism for Inhibiting the SUMO Pathway
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 64, Issue 2, Pages (August 2003)
Volume 145, Issue 2, Pages (August 2013)
Volume 10, Issue 1, Pages (July 2011)
Volume 132, Issue 4, Pages (April 2007)
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
Volume 138, Issue 1, Pages (January 2010)
Volume 131, Issue 6, Pages (December 2006)
Volume 138, Issue 3, Pages (March 2010)
Volume 93, Issue 5, Pages (May 1998)
Volume 132, Issue 5, Pages (May 2007)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
TNF-Induced Activation of the Nox1 NADPH Oxidase and Its Role in the Induction of Necrotic Cell Death  You-Sun Kim, Michael J. Morgan, Swati Choksi, Zheng-gang.
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2  Cecilia D. Sedano, Peter Sarnow  Cell Host &
Volume 138, Issue 7, Pages e1 (June 2010)
Volume 128, Issue 7, Pages (June 2005)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid  Jürgen Harder, Ulf Meyer-Hoffert,
Volume 127, Issue 4, Pages (October 2004)
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 67, Issue 6, Pages (June 2005)
Volume 24, Issue 6, Pages (December 2006)
Volume 128, Issue 7, Pages (June 2005)
Volume 70, Issue 5, Pages (September 2006)
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Volume 131, Issue 5, Pages (November 2006)
Volume 10, Issue 1, Pages (July 2011)
Volume 14, Issue 1, Pages (July 2013)
Presentation transcript:

Volume 137, Issue 5, Pages 1827-1835 (November 2009) The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2α Via Protein Kinase Activated by Double-Stranded RNA Activation  Menashe Elazar, Michael Liu, Sean A. McKenna, Ping Liu, Elizabeth A. Gehrig, Joseph D. Puglisi, Jean–François Rossignol, Jeffrey S. Glenn  Gastroenterology  Volume 137, Issue 5, Pages 1827-1835 (November 2009) DOI: 10.1053/j.gastro.2009.07.056 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 NTZ increases eIF2α phosphorylation. (A) Subgenomic replicon cells (RP7), (B) full-length replicon cells (FLRP1), and (C) Huh-7.5 cells infected with HCVcc virus (4 weeks before treatment). The cells were treated with the indicated NTZ concentrations at a final concentration of 0.5% dimethyl sulfoxide for 72 hours. Seventy-two hours after treatment the cells were harvested and equal amounts of protein were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis and Western blot for total and phosphorylated eIF2α. The relative amount of phosphorylated eIF2α in each lane was normalized to total eIF2α and expressed relative to the nontreated sample. Huh-7.5 cells stably carrying the (D) ATF-4 luciferase reporter or the (E) XBP/Ire1 luciferase reporter plasmids were infected with HCVcc and treated with NTZ for 24 hours as described in the Material and Methods section. As control, 1 μmol/L thapsigargin (tg) was added to noninfected cells for 12 hours before cell harvest and results were analyzed as the fold increase of luciferase activity relative to nontreated noninfected (nt/ni) cells. The mean and standard deviation are presented (n = 7). Gastroenterology 2009 137, 1827-1835DOI: (10.1053/j.gastro.2009.07.056) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 NTZ-induced eIF2α phosphorylation is greater in the presence of IFN. (A) Subgenomic replicon cells (RP7) were plated and treated as described in the Materials and Methods section in the presence or absence of 3 IU/mL IFN for 72 hours. The cells were harvested and analyzed as described in the Figure 1 legend. One micromolar of thapsigargin (tg) was added for 12 hours as a positive control for induction of eIF2α phosphorylation. (B) Huh-7.5 cells stably carrying the ATF-4 luciferase reporter plasmid were infected with HCVcc and treated with NTZ for 24 hours with or without 50 IU/mL IFN for the last 4 hours of incubation. As control, 1 μmol/L Tg was added to noninfected cells for 12 hours before cell harvest. The cells were harvested as described in the Materials and Methods section, and results were analyzed as the fold increase of ATF-4 luciferase activity relative to nontreated cells. The mean and standard deviation are presented (n = 7). Gastroenterology 2009 137, 1827-1835DOI: (10.1053/j.gastro.2009.07.056) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 NTZ increases PKR phosphorylation. Full-length HCV replicon cells were plated, treated with NTZ in the presence or absence of IFN, and harvested as described in the Materials and Methods section. The cell lysates were analyzed for the level of phosphorylated PKR, total PKR, and actin. The relative amounts of phosphorylated PKR were normalized to actin and expressed relative to the nontreated samples. Gastroenterology 2009 137, 1827-1835DOI: (10.1053/j.gastro.2009.07.056) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 NTZ increases PKR autophosphorylation in vitro. (A) Purified PKR (0.3 μmol/L) was incubated with HIV-TAR RNA activator (0.3 μmol/L) and N-eIF2α (2 μmol/L) in the presence of 32P-γATP and increasing amounts of NTZ. (B) Purified PKR (0.3 μmol/L) was incubated in the presence (top panel) or absence (bottom panel) of HIV-TAR RNA activator (0.3 μmol/L) in the presence of 32P-γATP and increasing amounts of NTZ. Gastroenterology 2009 137, 1827-1835DOI: (10.1053/j.gastro.2009.07.056) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 NTZ's effect on eIF2α phosphorylation is mediated via PKR activation. (A) Huh-7.5 cells were transfected with mock or HCV J6/JFH RNA with or without PKR inhibitor (VA1 RNA). Two hours after transfection, the cells were treated with NTZ or 0.5% dimethyl sulfoxide for 24 hours. Cells were harvested as described in the Figure 1 legend and the resulting lysates were analyzed for phosphorylated and total eIF2α. The relative amounts of phosphorylated eIF2α were normalized to total eIF2α and expressed relative to the nontreated sample. The figure represents at least 2 independent experiments. (B) Huh-7.5 cells were cotransfected with the ATF-4 luciferase reporter plasmid, a cytomegalovirus promoter–driven renilla luciferase expression plasmid, and a plasmid expressing either wild-type PKR or a dominant-negative form of PKR (K296R). Twenty-four hours after transfection the cells were infected with HCVcc and 2 hours after infection the cells were treated with NTZ as indicated for an additional 24 hours. The cells were harvested as described in the Materials and Methods section. The results were normalized to the renilla luciferase activity and presented as the fold increase of firefly luciferase activity relative to nontreated, PKR transfected cells. The mean and standard deviation of at least 3 transfections is shown. Gastroenterology 2009 137, 1827-1835DOI: (10.1053/j.gastro.2009.07.056) Copyright © 2009 AGA Institute Terms and Conditions